Published on in Vol 10, No 9 (2021): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/28669, first published .
Multiscale Biology of Cardiovascular Risk in Psoriasis: Protocol for a Case-Control Study

Multiscale Biology of Cardiovascular Risk in Psoriasis: Protocol for a Case-Control Study

Multiscale Biology of Cardiovascular Risk in Psoriasis: Protocol for a Case-Control Study

Journals

  1. Paganelli A, Righi V, Tarentini E, Magnoni C. Current Knowledge in Skin Metabolomics: Updates from Literature Review. International Journal of Molecular Sciences 2022;23(15):8776 View
  2. Prickett T, Pearson J, Troughton R, Kennedy M, Espiner E. The Predictive Value of A, B, and C-Type Natriuretic Peptides in People at Risk of Heart Disease: Protocol for a Longitudinal Observational Study. JMIR Research Protocols 2023;12:e37011 View
  3. Kvist-Hansen A, Kaiser H, Wang X, Krakauer M, Gørtz P, McCauley B, Zachariae C, Becker C, Hansen P, Skov L. Neutrophil Pathways of Inflammation Characterize the Blood Transcriptomic Signature of Patients with Psoriasis and Cardiovascular Disease. International Journal of Molecular Sciences 2021;22(19):10818 View
  4. Kaiser H, Wang X, Kvist-Hansen A, Krakauer M, Gørtz P, McCauley B, Skov L, Becker C, Hansen P. Biomarkers of subclinical atherosclerosis in patients with psoriasis. Scientific Reports 2021;11(1) View
  5. Sobolev V, Soboleva A, Denisova E, Pechatnikova E, Dvoryankova E, Korsunskaya I, Mezentsev A. Proteomic Studies of Psoriasis. Biomedicines 2022;10(3):619 View
  6. Kvist‐Hansen A, Kaiser H, Krakauer M, Gørtz P, Wang X, Becker C, Zachariae C, Hansen P, Skov L. Neutrophil‐to‐lymphocyte ratio and the systemic immune‐inflammation index as potential biomarkers of effective treatment and subclinical atherosclerotic cardiovascular disease in patients with psoriasis. Journal of the European Academy of Dermatology and Venereology 2023;37(5) View
  7. Wang X, Kaiser H, Kvist-Hansen A, McCauley B, Skov L, Hansen P, Becker C. IL-17 Pathway Members as Potential Biomarkers of Effective Systemic Treatment and Cardiovascular Disease in Patients with Moderate-to-Severe Psoriasis. International Journal of Molecular Sciences 2022;23(1):555 View
  8. Ricci M, Scriffignano S, Perrotta F, Carabellese B, Grivet Fojaja M, Cimini A, Lubrano E. PET imaging in the psoriasis and psoriatic arthritis field: un update. Clinical and Translational Imaging 2024;12(5):473 View